+ All Categories
Home > Documents > Group 5- Entoxi

Group 5- Entoxi

Date post: 30-Apr-2017
Category:
Upload: merilou-valencia
View: 214 times
Download: 0 times
Share this document with a friend
70
Mercury
Transcript
Page 1: Group 5- Entoxi

Mercury

Page 2: Group 5- Entoxi

Mercury• a metal that exists in three forms:

– Elemental (liquid at room temperature)– Inorganic salts– Component of organic compounds

• Exposure: inhalation & ingestion* Ingestion – most common route of exposure* Consumption of contaminated food – major source of

exposure* Inhalation & accidental ingestion of inorganic and organic

compounds (industry) – most common reason for toxic levels.

Page 3: Group 5- Entoxi

Mercury• Each form of mercury has different toxicologic

characteristics.– Elemental mercury (Hg0)

• can be ingested without significant effects• Inhalation is insignificant because of its low vapor

pressure• largely not absorbed because of its viscous liquid

nature.− Cationic mercury (Hg2+)

• Moderately toxic• Partially absorbed (inorganic Hg)

Page 4: Group 5- Entoxi

Mercury− Organic mercury

Methyl mercury (CH3Hg+) – very toxic• Not significantly absorbed• has significant local toxicity in the

gastrointestinal tract• rapidly and efficiently absorbed by passive

diffusion

Page 5: Group 5- Entoxi

Mercury Systemic organic mercury (hydrophobic

compartments)Results in high concentrations in brain and

peripheral nerves.Organic mercury is biotransformed to the divalent

state, allowing it to bind to neuronal proteinsElimination: renal filtration of bound low molecular

weight species or free (ionized) state.Elimination rate is slow; chronic exposure exerts a

cumulative effect

Page 6: Group 5- Entoxi

Mercury toxicity• a result of protein binding, which results in a change of

structure and function. • The most significant result of this interaction is the

inhibition of many enzymes. Acute gastrointestinal disturbances

− binding to intestinal proteins after ingestion of inorganic mercury

Severe bloody diarrhea− Ingestion of moderate amount− Ulceration and necrosis of the GI tract

Shock / Death− Severe cases

Page 7: Group 5- Entoxi

Clinical Significance• Tachycardia• Tremors• Thyroiditis• Disruption of renal function – most significant

– Glomerular proteinemia– Loss of tubular fxn

• Neurologic symptoms– Primary toxic effect of organic Hg.

Page 8: Group 5- Entoxi

Low levels of exposure causes

Higher levels of exposure result in

Tremors Hyporeflexia

Behavioral changes Hypotension

Mumbling speech Bradycardia

Loss of balance Renal dysfunction

Death

Page 9: Group 5- Entoxi

Atomic Absorption• Analysis of mercury• Uses whole blood or an aliquot of a 24-hr

urine specimen or anodal stripping volametry.• Requires special techniques as a result of the

volatility of elemental Hg.

Page 10: Group 5- Entoxi

Pesticides• are substances that have been intentionally

added in the environment to kill or harm undesirable life form

• Classified into several categories – insecticides, herbicides, etc.

• Purpose:been applied to the control of vector-

borne disease and urban peststo improve agricultural productivity

Page 11: Group 5- Entoxi

• Can be found in occupational settings and in the home frequent opportunities for exposure

• Contamination of food– major route of exposure to the general

public• Inhalation common occupational

• Transdermal adsorption and accidental routes

• Ingestion of exposure

Pesticides

Page 12: Group 5- Entoxi

• Action: target specific but (most) nonselective

toxic effects to many nontarget species (inc. human)

• Health effects:1. Short-term, low-level exposure

– Not yet ellucidated2. Extended low-level exposure

– may result to chronic disease states3. High-level exposure

– may result in acute disease states or death

Pesticides

Page 13: Group 5- Entoxi

• People applying the pesticide– most common victims of acute

poisoning • Ingestion by children – also common• Pesticide ingestion

– A common suicide vehicle

Pesticides

Page 14: Group 5- Entoxi

• Wide variation in the chemical configuration– from simple salts of heavy metals to complex

HMW-organic compounds• INSECTICIDES are the most prevalent of pesticides

– most common insecticides based on chem configuration

1. Organophosphate– most abundant pesticides– reponsible fo about 1/3 of all pesticide

poisoning2. Carbamates3. Halogenated hydocarbons

Pesticides

Page 15: Group 5- Entoxi

• Acetylcholinesterase inhibitor– action of organophosphates and

carbamates• in mammals

– acetylcholine is responsible for stimulation of muscle cells and several endocrine and exocrine glands

• action is terminated by postsynaptic acetylcholinesterase

inhibition of acetylcholinesterase

prolonged presence of acetylcholine on its receptor

Pesticides

Page 16: Group 5- Entoxi

Pesticides • Low-level of exposure

Salivation Lacrimation Involuntary urination and defecation

• Higher-level of exposure– Bradycardia -Slurred speech– Muscular twitching -Behavioral changes– Cramps -Death may occur– Apathy

Page 17: Group 5- Entoxi

Pesticides • Absorbed organoPO4 bind with high affinity to

proteins (acetylcholinesterase)• Protein binding

– prevents direct analysis = indirect measurement of acetylcholinesterase inhibition

sensitive and specific for organoPO4 exposure

Page 18: Group 5- Entoxi

• acetylcholinesterase – membrane-bound enzyme = low serum

activity1. Erythrocytic enzyme

– RBC that have high surface activity are commonly used to increase analytic sensitivity of the assay

– Not commonly performed

Pesticides: Lab Diagnosis

Page 19: Group 5- Entoxi

2. Serum pseudocholinesterase(SCHe)– alternative test– inhibited by organoPO4 in a similar

manner to the RBC enzyme – changes in the serum activity of SCHe

lack sensitivity and specificity for organoPO4 exposure

Pesticides: Lab Diagnosis

Page 20: Group 5- Entoxi

Pseudocholinesterase (SCHe)– found in liver, pancreas, brain, and serum– biologic fxn: not well defined– decrease level

• Acute infxn• Pulmonary embolism• Hepatitis • Cirrhosis

– several variants demo diminished activity

– not specific for organoPO4 poisoning

Page 21: Group 5- Entoxi

– normal ref range: 4000-12000 U/L– intraindividual variation

• degree of variance within an average individual• 700 U/L

• SCHe test is considered as screening test• Immediate antidotal therapy

– initiated in cases of suspected organoPO4 poisoning with decreased SCHe activity

Pseudocholinesterase (SCHe)

Page 22: Group 5- Entoxi

Toxicology of Therapeutic Drugs

Page 23: Group 5- Entoxi

Salicylates• Aspirin, Acetylsalicyclic acid• Analgesic, Antipyretic, Anti-inflammatory• Functions by decreasing thromboxane and

prostaglabin by inhibiting cyclooxygenase• Drawback: interferes with platelet aggregation

and GI function• Acidic in nature therefore excessive ingestion

is associated with metabolic acidosis

Page 24: Group 5- Entoxi

• Treatment: neutralization and elimination of excess acid

• GC or liquid chromatography have the highest analytic sensitivity and specificity

• Trinder reaction- most common chromogenic assay; reacts with salicyclate with ferric nitrate to form a colored complex

Page 25: Group 5- Entoxi

Acetaminophen (Tylenol)

• analgesic drugs• overdose is associated with a severe

hepatotoxicity2 forms:• Solely• In combination with other compound

Page 26: Group 5- Entoxi

Process of elimination:• Hepatic uptake• Biotransformation• Conjugation• ExcretionPathway of major concern: Hepatic mixed-function

oxidase system• Transformed into reactive intermediates• Conjugated with reduced glutathione

Page 27: Group 5- Entoxi

• In overdose situation- glutathione becomes depleted, reactive intermediate increases

• Nomograms are available that predict hepatotoxicity based on serum concentration

Page 28: Group 5- Entoxi

Toxicology of Drug Abuse• Drug Abuse

1.Drug Overdose- it is essential to identify the responsible agent to ensure appropriate treatment.

2. Drug Abuse in non overdose situation-provide rationale for treatment for addiction.

Page 29: Group 5- Entoxi

Testing for Drug Abuse• Involves screening of a single urine specimen

for many substances by qualitative screening procedures.

• This procedure detects only recent drug use.

• With abstinence of relatively short duration-abusing patient may not be identified

Page 30: Group 5- Entoxi

Testing for Drug Abuse• Evaluation of chronic abuse usually involves

several positive test results.

• A positive drug screen cannot discriminate between a single casual use and a chronic abuse.

Page 31: Group 5- Entoxi

Drug Abuse or Overdose• Prescription• Over-the-counter• Illicit drugs• Recreational or Performance enhancement

Purposes-most common

Page 32: Group 5- Entoxi

Testing for Drug Abuse• Testing for drug abuse has become

commonplace in: – Professional– Industrial – Athletic setting.

• The potential punitive measures associated with the testing may involve or result in criminal litigation .

Page 33: Group 5- Entoxi

Testing for Drug Abuse• Laboratories must ensure that data are legally

admissible and defendable.

• Analytic methods are used(accurate and precise)

• Documentation of specimen security.

• Protocols and procedures must be established to prevent and detect specimen adulteration.

Page 34: Group 5- Entoxi

Testing for Drug Abuse• Measurement of the ff.:

– Urinary temperature– PH– Specific Gravity – Creatinine

*to ensure that specimen has not been diluted or treated with substances that may interfere with testing.

Page 35: Group 5- Entoxi

Drug Abuse Testing1. Screening Test

– Simple– Rapid– Inexpensive– Capable of being automated

2.Confirmatory Test

Page 36: Group 5- Entoxi

Screening Test• Often referred to as “SPOT TESTS”

• Have good analytical sensitivity with marginal specificity.

• Detect classes of drugs based on similarities in chemical configuration.

• Allow detection of parent compounds and congeners which have similar effects.

Page 37: Group 5- Entoxi

Screening Test• Drawback

– May also detect chemically related substances that have no or low abuse potential .

*Interpretation of positive test results requires integration of clinical context and further testing.

Page 38: Group 5- Entoxi

Confirmatory test• Uses methods with high specificity and

sensitivity.

• Provide quantitative and qualitative information.

• GC-mass spectrophotometry (GC/MS)-Reference method for confirmation of most analytes.

Page 39: Group 5- Entoxi

General Analytic Procedures commonly used for Analysis of

Drug Abuse1. Chromogenic Reactions- used as screening

procedures.2. Immunoassay-based procedures-screening

and confirmatory assay. Offer a high degree of sensitivity and are easily automated.

Page 40: Group 5- Entoxi

Chromatography Technique1.Thin-layer Chromatography

• Inexpensive method for the screening of many drugs.

• No instrumentation is required. • Qualitative identification and

quantitation of drugs.

Page 41: Group 5- Entoxi

AMPHETAMINES

a stimulant used for narcolepsy and attention-deficit disorder

Initial effect: Increased mental and physical capacity along with a perception of well-being.

Followed by: Restlessness, irritability, possibly psychosis

Page 42: Group 5- Entoxi

AMPHETAMINES

Overdose (rare in experienced users): hypertension, cardiac arrhythmias,

convulsions, possibly death

OTC amphetamines: ephedrine, pseudoephedrine, and phenylpropanolamine

amphetamine-like compounds are common in allergy and cold medications

Page 43: Group 5- Entoxi

AMPHETAMINES

Screening: Immunoassay systems (urine)

Confirmatory: Liquid or Gas Chromatography

Page 44: Group 5- Entoxi

Usually administered orally in tablets (50-150 mg)

circulating half-life: 8-9 hours

eliminated by: hepatic metabolism (20% unchanged in urine)

onset if effect: 30-60 minutes (up to 3.5 hours)

MDMA“ECSTASY”

METHYLENEDIOXYMETHYLAMPHETAMINE

Page 45: Group 5- Entoxi

METHYLENEDIOXYMETHYLAMPHETAMINE

Desired effects: hallucinations, euphoria,

emphatic and emotional responses, and increased visual and tactile sensitivity

A screening test would usually not test positive, thus a confirmatory test must be

performed.

Page 46: Group 5- Entoxi

ANABOLIC STEROIDS

Chemically related to testosterone

used as therapy for male hypogonadism

increases muscle mass and improves athletic performance

ANABOLIC STEROIDSANABOLIC STEROIDSANDROGENIC

Page 47: Group 5- Entoxi

ANABOLIC ANDROGENIC STEROIDS

Chronic use of steroids: toxic hepatitis

accelerated arthrosclerosis abnormal aggregation of platelets (MI/stroke)

enlargement of the heart (death)

Malestesticular atrophy, sterility,

and impotence

Femalesmasculine traits, breast reduction

sterility

Page 48: Group 5- Entoxi

Screening Test:

Testosterone to Epitestosterone Ratio(T/E)

high ratios associated with exogenous testosterone testosterone

ANABOLIC ANDROGENIC STEROIDS

Page 49: Group 5- Entoxi

Cannabinoids• Group of psychoactive compounds found in

marijuana.• THC (tetrahydrocannabinol)- most potent and

abundant• Marijuana or Hashish (processed product) can

be smoked or ingested.

Page 50: Group 5- Entoxi
Page 51: Group 5- Entoxi

Cannabinoids• Subjected effect of exposure:

– Sense of well-being– Euphoria

• Associated with:– Impairment of short-term memory– Intellectual function

• Overdose has not been associated• With chronic use, Tolerance and mild

dependence may develop

Page 52: Group 5- Entoxi

Cannabinoids• THC – a lipophilic substance, rapidly removed from

the circulation by passive distribution into hydrophobic compartments, such as brain and fat.

• Results in slow elimination as a result of redistribution of back into circulation and subsequent hepatic metabolism

• Half life: – 1 day after a single use – 3-5 days in chronic, heavy consumers

• Hepatic metabolism products are eliminated in urine.

Page 53: Group 5- Entoxi

Cannabinoids• Major urinary metabolite

– 11-nor- - tetrahydrocannabinol-9-carboxylic acid(THC-COOH)

• Can be detected in urine:– 3-5 days after single use– 4 weeks in chronic

• Immunoassay for THC-COOH – screening test• GC/MC – confirmatory• Passive and Direct inhalation

Page 54: Group 5- Entoxi

Cocaine • An effective local anesthetic with a few

adverse effects at therapeutic concentrations• A potent CNS stimulator that elicits a sense of

excitement and euphoria• Administered directly

– Insufflation or intravenous injection– Inhaled as a vapor when smoked in the

free-base form (crack)

Page 55: Group 5- Entoxi
Page 56: Group 5- Entoxi

Cocaine • It has high abuse potential• Half life: 0.5-1 hr• Due to its short half life, it requires repeated

dosages of increasing quantity • Acute cocaine toxicity is associated:

– Hypertension– Arrhythmia– Seizure– MI

Page 57: Group 5- Entoxi

Cocaine • Primary factor that determines toxicity:

– Dose– Route of administration

• Intravenous administration-greatest hazard followed by smoking

• Cocaine’s short half-life is a result of rapid hepatic hydrolysis to inactivate metabolites. Major route of elimination.

Page 58: Group 5- Entoxi

Cocaine • Benzoylecgonine

– Primary product of hepatic metablism – Eliminated in the urine– Half life: 4-7 hours– Sensitive and specific indicator of

cocaine use– Detected in urine for up to 3 days after

single use and up to 20 days after the last dose for chronic heavy abusers

– Immunoassay (screening)– GC/MC (confirmatory)

Page 59: Group 5- Entoxi

Opiates• Class of substances capable of:

– Analgesia– Sedation– Anesthesia

• ALL derived from or chemically related to substances derived from the opium poppy

Page 60: Group 5- Entoxi

• Naturally occurring substances– Opium– Morphine– Codein

• Chemically modified forms of naturally occuring opiates– Heroin– hydromorphone

(Dilaudid)– oxycodone

(Percodan)• Common synthetic

opiates– Meperidine

(Demerol)– methadone

(Dolophine)– propoxyphene

(Darvon)– pentazocine

(Talwin)– fentanyl

(Sublimaze)

Opiates

Page 61: Group 5- Entoxi

• Have high level of overdose• Chronic use tolerance (physical and psychological dependence)• Acute overdose

– presents with respiratory acidosis– possibly an increase in serum indicators of

cardiac damage• High-level opiate overdose

– may lead to death• Tx: use of naloxone (opiate antagonist)

Opiates

Page 62: Group 5- Entoxi

• Laboratory test:1. Immunoassay

– initial screening– most are primarilly designed to detect morphine

and codeine– Cross-reactivity

2. GC/MS– confirmatory method of choice

Opiates

Page 63: Group 5- Entoxi

Phencyclidine (PCP)• an illicit drug• properties

– Stimulant– Depressant– Anesthetic– Hallucinogenic

• has high-abuse potential

Page 64: Group 5- Entoxi

• Adverse effects are commonly noted at doses that produce the desired subjective effects

• Overdose - assoc with coma and stupor• PCP can be

– ingested– inhaled (by smoking PCP-laced tobacco

or marijuana)

Phencyclidine (PCP)

Page 65: Group 5- Entoxi

• a lipophilic dug that rapidly distributes into fat and brain

• Elimination is slow• about 10-15%

– administered dose that is eliminated unchanged in the urine

• Hepatic metabolism forms various products

Phencyclidine (PCP)

Page 66: Group 5- Entoxi

• Detection of the parent drug in the urine– ID of PCP

• In chronic heavy users – PCP can be detected 7-30 days after

abstinence• Laboratory test:1. Immunoassay – screening procedure2. GC/MS – confirmatory method

Phencyclidine (PCP)

Page 67: Group 5- Entoxi

Sedative-Hypnotics• ALL members of this class are CNS depressants

• High to low abuse potential• Most common type of sedative hypnotics

abusedBarbiturates - have higher abuse

potentialBenzodiazipines -more commonly

found in abuse and overdose situations

Page 68: Group 5- Entoxi

• Commonly abused barbiturates:– Secobarbital– Pentobarbital– Phenobarbital

• Commonly abused benzodiazepines:– Diazepam

(Valium)– Lorazepam

(Ativan)– Chlordiazepoxide

(Librium)

Sedative-Hypnotics

Page 69: Group 5- Entoxi

• Initial overdose lethargy progress slurred speech

coma

• Respiratory depression– most serious toxic effect

• Hypotension – can occur with barbiturates• Toxicity of these agents is potentiated by ethanol

Sedative-Hypnotics

Page 70: Group 5- Entoxi

• Laboratory tests:1. Immunoassay

– most common screening for both barbiturates and benzodiazepines

– Broad cross-reactivity2. GC or Liquid chromatography

– Confirmatory test

Sedative-Hypnotics


Recommended